Tower Research Capital LLC (Trc) Lyra Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 15,123 shares of LYRA stock, worth $2,570. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,123

Previous 6,822 121.68%

Holding current value

$2,570

Previous $1,000 200.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.24 - $0.34 $1,992 - $2,822	8,301 Added 121.68%	15,123 $3,000
Q2 2024 Aug 13, 2024	SELL	$0.26 - $6.25 $545 - $13,118	-2,099 Reduced 23.53%	6,822 $1,000
Q1 2024 May 15, 2024	BUY	$4.55 - $6.53 $29,843 - $42,830	6,559 Added 277.69%	8,921 $55,000
Q4 2023 Feb 13, 2024	SELL	$2.82 - $5.24 $12,408 - $23,056	-4,400 Reduced 65.07%	2,362 $12,000
Q3 2023 Nov 14, 2023	BUY	$2.95 - $4.8 $15,694 - $25,536	5,320 Added 368.93%	6,762 $26,000
Q2 2023 Aug 14, 2023	SELL	$1.98 - $4.33 $16,889 - $36,934	-8,530 Reduced 85.54%	1,442 $5,000
Q1 2023 May 09, 2023	BUY	$1.95 - $3.09 $10,112 - $16,024	5,186 Added 108.36%	9,972 $20,000
Q4 2022 Feb 10, 2023	BUY	$2.44 - $5.42 $3,162 - $7,024	1,296 Added 37.13%	4,786 $15,000
Q3 2022 Nov 10, 2022	BUY	$4.95 - $6.6 $12,865 - $17,153	2,599 Added 291.69%	3,490 $17,000
Q2 2022 Aug 15, 2022	BUY	$4.12 - $7.51 $3,670 - $6,691	891 New	891 $5,000
Q1 2022 May 12, 2022	SELL	$3.5 - $5.36 $37,292 - $57,110	-10,655 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.22 - $9.41 $27,092 - $60,412	6,420 Added 151.59%	10,655 $47,000
Q3 2021 Nov 15, 2021	BUY	$6.06 - $9.43 $17,198 - $26,762	2,838 Added 203.15%	4,235 $38,000
Q2 2021 Aug 16, 2021	BUY	$6.91 - $12.59 $2,397 - $4,368	347 Added 33.05%	1,397 $11,000
Q1 2021 May 17, 2021	SELL	$10.38 - $15.61 $8,667 - $13,034	-835 Reduced 44.3%	1,050 $13,000
Q4 2020 Feb 16, 2021	SELL	$9.28 - $13.88 $20,369 - $30,466	-2,195 Reduced 53.8%	1,885 $21,000
Q3 2020 Nov 16, 2020	BUY	$10.61 - $13.96 $34,758 - $45,732	3,276 Added 407.46%	4,080 $46,000
Q2 2020 Aug 13, 2020	BUY	$10.91 - $18.56 $8,771 - $14,922	804 New	804 $9,000

Others Institutions Holding LYRA

# of Institutions

Shares Held

32.3M

Call Options Held

21.1K

Put Options Held

400

View Full List

About Lyra Therapeutics, Inc.

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $5.41M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

More about LYRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Lyra Therapeutics, Inc. Transaction History